Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036282 | SCV000059934 | likely benign | not specified | 2011-04-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620102 | SCV000736798 | likely benign | Cardiovascular phenotype | 2017-03-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000629081 | SCV000749994 | likely benign | Hypertrophic cardiomyopathy | 2024-12-20 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001180814 | SCV001345838 | likely benign | Cardiomyopathy | 2018-11-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001092524 | SCV001939226 | likely benign | not provided | 2018-09-04 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000629081 | SCV004819079 | likely benign | Hypertrophic cardiomyopathy | 2023-12-13 | criteria provided, single submitter | clinical testing |